This patient survived a dozen tumors. Here’s what we can learn from their unique immune system

Credit: Op-Med
Credit: Op-Med

A unique patient who has survived the development of a dozen tumors could hold the key to curing cancer, a new study reveals.

Their review found that the individual is “programmed” to develop different forms of the disease after inheriting mutations in a gene from both parents. However, their immune system naturally generates a strong anti-inflammatory response that fights the growths. Knowing how it does this offers a “groundbreaking” hope of earlier disease diagnosis and new immunotherapy drugs.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

The unnamed patient around the age of 40 has had 12 tumors, with at least five of them being malignant. The first developed during infancy, followed by others every few years. Each has been of a different type and in a different part of the body. The patient also has skin spots, the birth defect microcephaly which causes a smaller head and brain, and other alterations.

According to Malumbres, the study of this unique case opens up “a way to detect cells with tumor potential well in advance of clinical tests and diagnostic imaging. It also provides a novel way to stimulate the immune response to a cancerous process.”

This is an excerpt. Read the full article here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.